Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver

被引:22
作者
He, QR [1 ]
Johnson, VJ [1 ]
Osuchowski, MF [1 ]
Sharma, RR [1 ]
机构
[1] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA
关键词
D O I
10.1023/B:MYCO.0000024182.04140.95
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Myriocin, a fungal metabolite isolated from Myriococcum albomyces, Isaria sinclairi, and Mycelia sterilia, is a potent inhibitor of serine palmitoyltransferase (SPT), a key enzyme in de novo synthesis of sphingolipids. To evaluate the biological effects of myriocin in vivo, we investigated the levels of free sphingoid bases and expression of selected genes regulating cell growth in mouse liver. Male Balb/c mice, weighing 22 g were injected intraperitoneally with myriocin at 0, 0.1, 0.3, and 1.0 mg kg(-1) body weight daily for 5 days. Animals were euthanized 24 hours after the last treatment. Levels of plasma alanine aminotransferase and aspartate aminotransferase were not significantly altered by the treatment. A dose-dependent decrease in free sphinganine but not sphingosine was detected by high performance liquid chromatography in both liver and kidney. The decrease of free sphinganine paralleled the decrease in SPT activity. Reverse transcriptase polymerase chain reaction analysis on liver mRNA revealed an increase in expression of c-myc, but no changes in tumor necrosis factor alpha, transforming growth factor beta, and hepatocyte growth factor. Results showed that myriocin blocked de novo synthesis of sphingolipids in vivo by SPT inhibition and induced c-myc expression in liver.
引用
收藏
页码:339 / 347
页数:9
相关论文
共 35 条
[21]   SERINE PALMITOYLTRANSFERASE IS THE PRIMARY TARGET OF A SPHINGOSINE-LIKE IMMUNOSUPPRESSANT, ISP-1/MYRIOCIN [J].
MIYAKE, Y ;
KOZUTSUMI, Y ;
NAKAMURA, S ;
FUJITA, T ;
KAWASAKI, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (02) :396-403
[22]   Dual roles of sphingolipids in signaling of the escape from and onset of apoptosis in a mouse cytotoxic T-cell line, CTLL-2 [J].
Nakamura, S ;
Kozutsumi, Y ;
Sun, YD ;
Miyake, Y ;
Fujita, T ;
Kawasaki, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (03) :1255-1257
[23]   Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis [J].
Riley, RT ;
Enongene, E ;
Voss, KA ;
Norred, WP ;
Meredith, FI ;
Sharma, RP ;
Spitsbergen, J ;
Williams, DE ;
Carlson, DB ;
Merrill, AH .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 :301-308
[24]   Serine palmitoyltransferase inhibition reverses anti-proliferative effects of ceramide synthase inhibition in cultured renal cells and suppresses free sphingoid base accumulation in kidney of BALBc mice [J].
Riley, RT ;
Voss, KA ;
Norred, WP ;
Bacon, CW ;
Meredith, FI ;
Sharma, RP .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 1999, 7 (02) :109-118
[25]   Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases [J].
Schmelz, EM ;
Dombrink-Kurtzman, MA ;
Roberts, PC ;
Kozutsumi, Y ;
Kawasaki, T ;
Merrill, AH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 148 (02) :252-260
[26]   Signaling networks that link cell proliferation and cell fate [J].
Sears, RC ;
Nevins, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :11617-11620
[27]   Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor [J].
Sharma, RP ;
Bhandari, N ;
Riley, RT ;
Voss, KA ;
Meredith, FI .
TOXICOLOGY, 2000, 143 (02) :183-194
[28]   Demonstration of in-situ apoptosis in mouse liver and kidney after short-term repeated exposure to fumonisin B1 [J].
Sharma, RP ;
Dugyala, RR ;
Voss, KA .
JOURNAL OF COMPARATIVE PATHOLOGY, 1997, 117 (04) :371-381
[29]   Apoptotic and anti-proliferative effects of fumonisin B-1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells [J].
Tolleson, WH ;
Melchior, WB ;
Morris, SM ;
McGarrity, LJ ;
Domon, OE ;
Muskhelishvili, L ;
James, SJ ;
Howard, PC .
CARCINOGENESIS, 1996, 17 (02) :239-249
[30]   An overview of rodent toxicities:: Liver and kidney effects of fumonisins and Fusarium moniliforme [J].
Voss, KA ;
Riley, RT ;
Norred, WP ;
Bacon, CW ;
Meredith, FI ;
Howard, PC ;
Plattner, RD ;
Collins, TFX ;
Hansen, DK ;
Porter, JK .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 :259-266